227 related articles for article (PubMed ID: 32416413)
1. Covid-19 management with inflammation resolving mediators? Perspectives and potential.
Regidor PA
Med Hypotheses; 2020 Sep; 142():109813. PubMed ID: 32416413
[No Abstract] [Full Text] [Related]
2. More questions than answers, and a way ahead.
La Manna G
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281753
[No Abstract] [Full Text] [Related]
3. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
4. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
5. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
DiNicolantonio JJ; Barroso J; McCarty M
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32895293
[No Abstract] [Full Text] [Related]
6. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
[No Abstract] [Full Text] [Related]
7. Old and new antirheumatic drugs for the treatment of COVID-19.
Benucci M; Damiani A; Infantino M; Manfredi M; Quartuccio L
Joint Bone Spine; 2020 May; 87(3):195-197. PubMed ID: 32321635
[No Abstract] [Full Text] [Related]
8. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
Bou Khalil R
Med Hypotheses; 2020 Sep; 142():109798. PubMed ID: 32413699
[No Abstract] [Full Text] [Related]
9. After 62 years of regulating immunity, dexamethasone meets COVID-19.
Cain DW; Cidlowski JA
Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
[TBL] [Abstract][Full Text] [Related]
10. Audio Interview: Tocilizumab and Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
[No Abstract] [Full Text] [Related]
11. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
Chrousos GP; Meduri GU
Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
[No Abstract] [Full Text] [Related]
12. [Not Available].
Balavoine JF
Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
[No Abstract] [Full Text] [Related]
13. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19.
Moutsopoulos HM
Ann Rheum Dis; 2020 Sep; 79(9):1253-1254. PubMed ID: 32345616
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
[No Abstract] [Full Text] [Related]
15. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
16. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
Poulas K; Farsalinos K; Zanidis C
Front Immunol; 2020; 11():1373. PubMed ID: 32612613
[No Abstract] [Full Text] [Related]
17. Cell and animal models of SARS-CoV-2 pathogenesis and immunity.
Leist SR; Schäfer A; Martinez DR
Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32887790
[TBL] [Abstract][Full Text] [Related]
18. Targeting inflammation and cytokine storm in COVID-19.
Huang Q; Wu X; Zheng X; Luo S; Xu S; Weng J
Pharmacol Res; 2020 Sep; 159():105051. PubMed ID: 32603772
[No Abstract] [Full Text] [Related]
19. COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause.
Fernandez-Gutierrez B
Reumatol Clin (Engl Ed); 2020; 16(4):253-254. PubMed ID: 32345483
[No Abstract] [Full Text] [Related]
20. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients.
Liao S; Zhan K; Gan L; Bai Y; Li J; Yuan G; Cai Y; Zhang A; He S; Mei Z
Signal Transduct Target Ther; 2020 Oct; 5(1):255. PubMed ID: 33130825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
